Oral alendronate therapy for severe vitamin D intoxication of the infant with nephrocalcinosis

Atabek, MEPirgon, OSert, A2020-03-262020-03-2620060334-018Xhttps://hdl.handle.net/20.500.12395/20604Vitamin D intoxication is a well-known cause of hypercalcemia in children. We report here the use of oral alendronate for the treatment of hypercalcemia due to vitamin D intoxication in a 7 month-old infant with nephrocalcinosis. The serum calcium levels were normalized without complications. Oral alendronate therapy may be safely used in hypercalcemia due to vitamin. D intoxication in pediatric patients with nephrocalcinosis resistant to hydration, diuretics or corticosteroids.eninfo:eu-repo/semantics/closedAccessoral alendronate therapyinfantvitamin D intoxicationOral alendronate therapy for severe vitamin D intoxication of the infant with nephrocalcinosisArticle19216917216562591Q2WOS:000236264300011Q4